BhattABFosterEKuehlKAlpertJ; American Heart Association Council on Clinical Cardiology. Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation. 2015;131(21):1884–1931. doi:10.1161/CIR.0000000000000204.
2.
BaumgartnerHBonhoefferPDe GrootNMde HaanF; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC); Association for European Paediatric Cardiology (AEPC); ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–2957. doi:10.1093/eurheartj/ehq249.
3.
SilversidesCKKiessMBeauchesneL. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26(3):e80–e97.
4.
MurdochJLWalkerBAHalpernBLKuzmaJWMcKusickVA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med. 1972;286(15):804–808.
5.
MarelliAGilboaSDevineO. Estimating the congenital heart disease population in the United States in 2010—what are the numbers?J Am Coll Cardiol. 2012;59(13s1):e787–e787. doi:10.1016/S0735-1097(12)60788-8.
6.
JacobsML. Pediatric cardiac surgery: the long view. Circulation. 2015;131(4):328–330. doi:10.1161/CIRCULATIONAHA.114.014318.
